Safety guidelines for sharps use in diabetes treatment
A group of medical professionals from 13 countries has agreed new global recommendations on ensuring the safety of patients and health-care workers relating to the use of needle injections for the treatment of diabetes.
The recommendations, published by the Workshop on Injection Safety in Endocrinology (WISE) consensus group, were informed by the results of a four-month survey of sharps injuries among 634 nurses from 13 western European countries and Russia. This research an and other issues were discussed at the WISE event in October last year, which brought together a diverse group of 58 leaders in the field of diabetes safety from countries including the UK, France, Germany, Italy, Spain, Russia, Canada and the USA.
€
Safety guidelines for sharps use in diabetes treatment
A group of medical professionals from 13 countries has agreed new global recommendations on ensuring the safety of patients and health-care workers relating to the use of needle injections for the treatment of diabetes.
Safety & Health Practitioner
SHP - Health and Safety News, Legislation, PPE, CPD and Resources Related Topics
Approach with caution – choosing the right wellbeing practitioner
UK Government says Employee Rights Bill is ‘upgrade’ for workers’ rights
Wellbeing requires definition to help employers, report says